- Home
- GSRT vs AQST Comparison
GSRT vs AQST Comparison
Compare GSRT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSRT
- AQST
- Stock Information
- Founded
- GSRT 2023
- AQST 2004
- Country
- GSRT United States
- AQST United States
- Employees
- GSRT N/A
- AQST N/A
- Industry
- GSRT
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- GSRT
- AQST Health Care
- Exchange
- GSRT Nasdaq
- AQST Nasdaq
- Market Cap
- GSRT 292.9M
- AQST 254.1M
- IPO Year
- GSRT 2024
- AQST 2018
- Fundamental
- Price
- GSRT $10.24
- AQST $2.76
- Analyst Decision
- GSRT
- AQST Strong Buy
- Analyst Count
- GSRT 0
- AQST 5
- Target Price
- GSRT N/A
- AQST $11.40
- AVG Volume (30 Days)
- GSRT 497.0K
- AQST 984.2K
- Earning Date
- GSRT 01-01-0001
- AQST 05-12-2025
- Dividend Yield
- GSRT N/A
- AQST N/A
- EPS Growth
- GSRT N/A
- AQST N/A
- EPS
- GSRT 0.10
- AQST N/A
- Revenue
- GSRT N/A
- AQST $57,561,000.00
- Revenue This Year
- GSRT N/A
- AQST N/A
- Revenue Next Year
- GSRT N/A
- AQST $39.51
- P/E Ratio
- GSRT $98.61
- AQST N/A
- Revenue Growth
- GSRT N/A
- AQST 13.79
- 52 Week Low
- GSRT $9.86
- AQST $2.20
- 52 Week High
- GSRT $10.25
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- GSRT N/A
- AQST 48.51
- Support Level
- GSRT N/A
- AQST $2.65
- Resistance Level
- GSRT N/A
- AQST $3.05
- Average True Range (ATR)
- GSRT 0.00
- AQST 0.16
- MACD
- GSRT 0.00
- AQST 0.00
- Stochastic Oscillator
- GSRT 0.00
- AQST 50.51
About GSRT GSR III Acquisition Corp. Ordinary Shares
GSR III Acquisition Corp is a blank check company.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.